Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Microsatellite Repeats | 3 | 2019 | 99 | 1.07 | Why? |
| Acute Kidney Injury | 7 | 2021 | 5762 | 0.89 | Why? |
| Sepsis | 6 | 2019 | 3517 | 0.75 | Why? |
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2018 | 45 | 0.75 | Why? |
| Immune Tolerance | 1 | 2021 | 608 | 0.63 | Why? |
| Gene Frequency | 2 | 2019 | 1210 | 0.57 | Why? |
| Renal Replacement Therapy | 3 | 2020 | 1530 | 0.56 | Why? |
| Polymorphism, Genetic | 2 | 2019 | 1074 | 0.56 | Why? |
| Cardiovascular Agents | 1 | 2020 | 663 | 0.54 | Why? |
| Ascorbic Acid | 1 | 2020 | 676 | 0.54 | Why? |
| Extracorporeal Membrane Oxygenation | 3 | 2020 | 5002 | 0.51 | Why? |
| Hemodynamics | 1 | 2020 | 1562 | 0.47 | Why? |
| MicroRNAs | 3 | 2019 | 1787 | 0.45 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.44 | Why? |
| Vitamins | 1 | 2020 | 1208 | 0.43 | Why? |
| Thrombocytopenia | 2 | 2021 | 2093 | 0.42 | Why? |
| Hemofiltration | 1 | 2011 | 155 | 0.40 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.31 | Why? |
| Ultrasonography | 1 | 2021 | 4409 | 0.29 | Why? |
| Intensive Care Units | 9 | 2021 | 29594 | 0.28 | Why? |
| Consensus | 2 | 2020 | 6345 | 0.26 | Why? |
| Apoptosis | 3 | 2018 | 2335 | 0.26 | Why? |
| Respiration, Artificial | 5 | 2021 | 22116 | 0.26 | Why? |
| Hospital Mortality | 4 | 2020 | 22087 | 0.24 | Why? |
| China | 14 | 2021 | 50654 | 0.24 | Why? |
| Inflammation | 3 | 2021 | 13255 | 0.23 | Why? |
| Pneumonia, Viral | 13 | 2020 | 243684 | 0.22 | Why? |
| Genetics, Population | 2 | 2018 | 162 | 0.22 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.21 | Why? |
| Prognosis | 6 | 2021 | 32490 | 0.21 | Why? |
| Genetic Loci | 2 | 2018 | 439 | 0.20 | Why? |
| Rats | 3 | 2019 | 2764 | 0.20 | Why? |
| Pragmatic Clinical Trials as Topic | 2 | 2020 | 350 | 0.20 | Why? |
| Acute Lung Injury | 2 | 2019 | 904 | 0.20 | Why? |
| Benzylidene Compounds | 1 | 2019 | 26 | 0.19 | Why? |
| Administration, Intravenous | 2 | 2020 | 1115 | 0.19 | Why? |
| Membrane Potentials | 1 | 2018 | 56 | 0.19 | Why? |
| Glyburide | 1 | 2017 | 17 | 0.18 | Why? |
| Transforming Growth Factors | 1 | 2017 | 1 | 0.18 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.18 | Why? |
| Antigens, CD19 | 1 | 2018 | 98 | 0.18 | Why? |
| Mesenchymal Stem Cell Transplantation | 2 | 2020 | 1322 | 0.18 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.18 | Why? |
| Vital Signs | 1 | 2020 | 257 | 0.18 | Why? |
| Adoptive Transfer | 1 | 2019 | 250 | 0.17 | Why? |
| Cord Blood Stem Cell Transplantation | 1 | 2019 | 143 | 0.17 | Why? |
| Rats, Wistar | 1 | 2019 | 621 | 0.17 | Why? |
| Anesthetics, Intravenous | 1 | 2018 | 98 | 0.17 | Why? |
| Amikacin | 1 | 2017 | 62 | 0.17 | Why? |
| Lipopolysaccharides | 2 | 2019 | 848 | 0.17 | Why? |
| Neural Stem Cells | 1 | 2018 | 135 | 0.17 | Why? |
| Cystatin C | 1 | 2017 | 125 | 0.16 | Why? |
| Principal Component Analysis | 1 | 2019 | 689 | 0.16 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.16 | Why? |
| Critical Illness | 4 | 2021 | 17281 | 0.15 | Why? |
| Lung | 3 | 2021 | 31049 | 0.15 | Why? |
| Chemoprevention | 1 | 2020 | 585 | 0.15 | Why? |
| Propofol | 1 | 2018 | 172 | 0.15 | Why? |
| Enteral Nutrition | 1 | 2018 | 320 | 0.15 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 520 | 0.15 | Why? |
| Cell Differentiation | 2 | 2019 | 1338 | 0.14 | Why? |
| Macrophages, Alveolar | 1 | 2019 | 668 | 0.14 | Why? |
| Bilirubin | 1 | 2017 | 503 | 0.14 | Why? |
| Carbon Dioxide | 2 | 2020 | 917 | 0.14 | Why? |
| Male | 24 | 2021 | 367725 | 0.14 | Why? |
| Ventilator Weaning | 1 | 2019 | 536 | 0.14 | Why? |
| Aged | 16 | 2021 | 215776 | 0.13 | Why? |
| Humans | 38 | 2021 | 930598 | 0.13 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.13 | Why? |
| Treatment Outcome | 8 | 2020 | 51732 | 0.13 | Why? |
| Sex Factors | 3 | 2020 | 11014 | 0.13 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.13 | Why? |
| Rats, Sprague-Dawley | 2 | 2018 | 987 | 0.12 | Why? |
| Glycoproteins | 1 | 2018 | 615 | 0.12 | Why? |
| Pyridines | 1 | 2019 | 680 | 0.12 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.12 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.12 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.12 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2018 | 760 | 0.12 | Why? |
| Female | 19 | 2021 | 380317 | 0.12 | Why? |
| Pneumothorax | 1 | 2020 | 758 | 0.11 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.11 | Why? |
| Carcinoma, Hepatocellular | 2 | 2020 | 1222 | 0.11 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.11 | Why? |
| Heart | 1 | 2020 | 1791 | 0.10 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.10 | Why? |
| CRISPR-Cas Systems | 1 | 2019 | 1397 | 0.10 | Why? |
| Patient Discharge | 3 | 2020 | 5696 | 0.10 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.10 | Why? |
| Cough | 2 | 2020 | 4891 | 0.10 | Why? |
| Coronary Vessels | 1 | 2017 | 914 | 0.10 | Why? |
| HMGB1 Protein | 1 | 2011 | 223 | 0.10 | Why? |
| Pandemics | 15 | 2021 | 389249 | 0.10 | Why? |
| Liver Neoplasms | 2 | 2020 | 1666 | 0.10 | Why? |
| Cytokines | 1 | 2011 | 15010 | 0.09 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2017 | 861 | 0.09 | Why? |
| Pain | 1 | 2017 | 1084 | 0.09 | Why? |
| Fever | 3 | 2020 | 7795 | 0.09 | Why? |
| Animals | 8 | 2019 | 78931 | 0.09 | Why? |
| Pain Management | 1 | 2017 | 854 | 0.09 | Why? |
| Statistics, Nonparametric | 1 | 2011 | 1008 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.09 | Why? |
| Interleukin-1 | 1 | 2011 | 438 | 0.09 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.09 | Why? |
| Bacterial Infections | 1 | 2021 | 2229 | 0.09 | Why? |
| Delirium | 1 | 2017 | 1061 | 0.08 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.08 | Why? |
| Mice | 4 | 2019 | 21357 | 0.08 | Why? |
| Macrophages | 1 | 2019 | 2784 | 0.08 | Why? |
| Gene Expression Regulation | 1 | 2019 | 4020 | 0.08 | Why? |
| Monocytes | 1 | 2019 | 2978 | 0.08 | Why? |
| Interleukin-1beta | 1 | 2011 | 992 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2019 | 3629 | 0.07 | Why? |
| Adult | 11 | 2021 | 244371 | 0.07 | Why? |
| Alanine Transaminase | 1 | 2011 | 1329 | 0.07 | Why? |
| Creatinine | 1 | 2011 | 1443 | 0.07 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.07 | Why? |
| Palliative Care | 1 | 2020 | 2665 | 0.07 | Why? |
| Organ Transplantation | 1 | 2020 | 2616 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.07 | Why? |
| Interleukin-10 | 1 | 2011 | 1409 | 0.07 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.06 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.06 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.06 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2019 | 3361 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.06 | Why? |
| Multicenter Studies as Topic | 2 | 2020 | 2437 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.06 | Why? |
| Kaplan-Meier Estimate | 1 | 2011 | 4260 | 0.06 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.06 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2011 | 2483 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Karyotype | 1 | 2019 | 16 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Embryonic Stem Cells | 1 | 2019 | 66 | 0.05 | Why? |
| Anorexia | 1 | 2020 | 194 | 0.05 | Why? |
| Calcium Channels, N-Type | 1 | 2018 | 2 | 0.05 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2019 | 119 | 0.05 | Why? |
| Receptors, GABA-B | 1 | 2018 | 4 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.05 | Why? |
| Paternity | 1 | 2018 | 7 | 0.05 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.05 | Why? |
| DNA Fingerprinting | 1 | 2018 | 41 | 0.05 | Why? |
| Vidarabine | 1 | 2018 | 59 | 0.05 | Why? |
| Gene Knockout Techniques | 1 | 2019 | 347 | 0.05 | Why? |
| Umbilical Cord | 1 | 2020 | 358 | 0.04 | Why? |
| Disease Models, Animal | 2 | 2017 | 10998 | 0.04 | Why? |
| Hemorheology | 1 | 2017 | 17 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Human Embryonic Stem Cells | 1 | 2019 | 199 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2019 | 5814 | 0.04 | Why? |
| Drainage | 1 | 2020 | 414 | 0.04 | Why? |
| Midazolam | 1 | 2017 | 79 | 0.04 | Why? |
| Evidence-Based Medicine | 2 | 2020 | 3228 | 0.04 | Why? |
| Liver | 1 | 2011 | 4007 | 0.04 | Why? |
| Haloperidol | 1 | 2017 | 78 | 0.04 | Why? |
| Dyspnea | 2 | 2020 | 3847 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2020 | 6543 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2017 | 391 | 0.04 | Why? |
| Hematopoietic Stem Cells | 1 | 2019 | 321 | 0.04 | Why? |
| Anastomosis, Surgical | 1 | 2017 | 169 | 0.04 | Why? |
| Cyclophosphamide | 1 | 2018 | 387 | 0.04 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Random Allocation | 1 | 2019 | 773 | 0.04 | Why? |
| APACHE | 1 | 2018 | 682 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.04 | Why? |
| Chest Pain | 1 | 2020 | 578 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.04 | Why? |
| Microscopy, Confocal | 1 | 2017 | 343 | 0.04 | Why? |
| Fentanyl | 1 | 2017 | 142 | 0.04 | Why? |
| Dexmedetomidine | 1 | 2017 | 130 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Fluid Therapy | 1 | 2020 | 628 | 0.04 | Why? |
| MAP Kinase Signaling System | 1 | 2017 | 360 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Colistin | 1 | 2017 | 217 | 0.03 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2019 | 624 | 0.03 | Why? |
| Nursing Care | 1 | 2020 | 328 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2020 | 1638 | 0.03 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.03 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Recombinant Fusion Proteins | 1 | 2018 | 919 | 0.03 | Why? |
| Hepatitis B virus | 1 | 2020 | 882 | 0.03 | Why? |
| Safety | 1 | 2020 | 1583 | 0.03 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2018 | 1475 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Hepatitis B | 1 | 2020 | 888 | 0.03 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Coronary Artery Bypass | 1 | 2017 | 629 | 0.03 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.03 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.02 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Endothelial Cells | 1 | 2019 | 2048 | 0.02 | Why? |
| Swine | 1 | 2017 | 3352 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.02 | Why? |
| Liver Transplantation | 1 | 2020 | 2864 | 0.02 | Why? |
| Drugs, Chinese Herbal | 1 | 2020 | 2760 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| Kidney Failure, Chronic | 1 | 2020 | 3222 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.02 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.00 | Why? |
Peng's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(244)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(306)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_